ACR releases new appropriateness criteria promoting patient-centered care

New appropriateness criteria created to get patients more involved in their own care have been released today, online in the Journal of the American College of Radiology.

The summaries may be a “first-of-its kind” series of summaries to help patients understand which imaging tests may be most appropriate, if any, for their condition, according to an ACR press release.

“We expect ordering physicians, radiologists and patients will welcome these summaries. They can help providers explain why they are requesting a certain imaging test or no test at all. This helps patients more fully participate in their care and promotes a better doctor-patient relationship,” said Bruce J. Hillman, MD, JACR Editor-In Chief in the release. “They also will promote radiologists’ involvement in the health care team,” he added.

The criteria are made up of 237 evidence-based guidelines in what is described as possibly the first time a medical association has produced these types of patient-friendly guidelines. The effort is part of an overarching ACR initiative to move toward more patient- and family-centered radiology care, according to the same brief.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.